{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:16:14Z","timestamp":1771049774468,"version":"3.50.1"},"reference-count":125,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PRI"],"published-print":{"date-parts":[[2020,11,26]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Acne vulgaris a chronic disease which is caused by blockage of the sebaceous gland is commonly seen in almost every human being at some point in their lives. There are 20-25% chances of progression of acne to severe cases, which leads to permanent scarring that results in psychological problems like depression, social isolation, lowered self-esteem, and lowered self-confidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>Though several conventional treatments are available in the market but still there are various adverse effects associated with topical anti-acne agents due to which it lacks patient compatibility. The present study is undertaken to find out the major shortcoming; why the current therapies do not give the desired therapeutic results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Novel drug delivery strategies can play a crucial role in the enhancement of topical delivery of anti-acne agents by escalating their dermal localization and reducing their adverse effects. Consumption of medicinal plants like Aloe vera, Withania somniferia etc. have clinical evidence regarding the effective management of acne. The current inclination towards nanotechnology is considerable due to several changes in the pharmaceutical research area. To secure the research work in different pharmaceutical fields, patents are filed against various agents like Galderma Research &amp; Development have filed patents for adapalene and benzoyl peroxide for the management of acne vulgaris. The current review highlights the potential of various novel drug delivery approaches like liposomes, niosomes, ethosomes, transfersomes etc. in enhancing the topical delivery of anti-acne agents.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1574891x15999200729192138","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T11:11:36Z","timestamp":1596107496000},"page":"3-29","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Current Insights for the Management of Acne in the Modern Era"],"prefix":"10.2174","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-2253","authenticated-orcid":true,"given":"Neha","family":"Singh","sequence":"first","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2334-8643","authenticated-orcid":true,"given":"Apoorva","family":"Singh","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5810-0501","authenticated-orcid":true,"given":"Kalpana","family":"Pandey","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6566-6335","authenticated-orcid":true,"family":"Nimisha","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University, Lucknow, Uttar Pradesh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/276260","volume":"2014","author":"Vyas A","year":"2014","unstructured":"Vyas A; Kumar Sonker A; Gidwani B.; Carrier-based drug delivery system for treatment of acne. Sci World J 2014,2014","journal-title":"Sci World J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/abd1806-4841.20153969","volume":"90","author":"Sittart J.A.","year":"2015","unstructured":"Sittart J.A.; Costa Ad, Mulinari-Brenner F, Follador I, Azulay-Abulafia L, Castro LC. Multicenter study for efficacy and safety evaluation of a fixeddose combination gel with adapalen 0.1% and benzoyl peroxide 2.5% (Epiduo\u00ae for the treatment of acne vulgaris in Brazilian population. An Bras Dermatol 2015,90(6)(Suppl. 1),1-16","journal-title":"An Bras Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-2133.1971.tb07195.x","volume":"85","author":"Burton J.L.","year":"1971","unstructured":"Burton J.L.; Cunliffe W.J.; Stafford I.; Shuster S.; The prevalence of acne vulgaris in adolescence. Br J Dermatol 1971,85(2),119-126","journal-title":"Br J Dermatol"},{"key":"ref=4","first-page":"35","author":"Plewig G.","year":"2019","unstructured":"Plewig G.; Melnik B.; Chen W.; Acne Epidemiology and genetics InPlewig and Kligman\u2019s acne and rosacea 2019,35-44","journal-title":"Acne Epidemiology and genetics InPlewig and Kligman\u2019s acne and rosacea"},{"key":"ref=5","first-page":"133","volume":"46","author":"G\u00f6tz H.","year":"1971","unstructured":"G\u00f6tz H.; Zabel G.; Acne vulgaris in 2,249 high-school students in the 12-20 years age group G Ital Dermatol Minerva Dermatol 1971,46(3),133-136","journal-title":"G Ital Dermatol Minerva Dermatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1136\/bmj.298.6682.1217","volume":"298","author":"Rademaker M.","year":"1989","unstructured":"Rademaker M.; Garioch J.J.; Simpson N.B.; Acne in schoolchildren: no longer a concern for dermatologists. BMJ 1989,298(6682),1217-1219","journal-title":"BMJ"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1046\/j.1365-2133.2001.04290.x","volume":"145","author":"Sch\u00e4fer T.","year":"2001","unstructured":"Sch\u00e4fer T.; Nienhaus A.; Vieluf D.; Berger J.; Ring J.; Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001,145(1),100-104","journal-title":"Br J Dermatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1610-0387.2005.05876.x","volume":"4","author":"Rzany B.","year":"2006","unstructured":"Rzany B.; Kahl C.; Epidemiology of acne vulgaris J Dtsch Dermatol Ges 2006,4(1),8-9","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1136\/bmj.1.6171.1109","volume":"1","author":"Cunliffe W.J.","year":"1979","unstructured":"Cunliffe W.J.; Gould D.J.; Prevalence of facial acne vulgaris in late adolescence and in adults. BMJ 1979,1(6171),1109-1110","journal-title":"BMJ"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1046\/j.1468-3083.2001.00357.x","volume":"15","author":"Poli F.","year":"2001","unstructured":"Poli F.; Dreno B.; Verschoore M.; An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001,15(6),541-545","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2340\/0001555572148149","volume":"72","author":"Fyrand O.","year":"1992","unstructured":"Fyrand O.; Fiskaadal H.J.; Trygstad O.; Acne in pubertal boys undergoing treatment with androgens. Acta Derm Venereol 1992,72(2),148-149","journal-title":"Acta Derm Venereol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000057878","volume":"204","author":"Jemec G.B.","year":"2002","unstructured":"Jemec G.B.; Linneberg A.; Nielsen N.H.; Fr\u00f8lund L.; Madsen F.; J\u00f8rgensen T.; Have oral contraceptives reduced the prevalence of acne? a population-based study of acne vulgaris, tobacco smoking and oral contraceptives. Dermatology (Basel) 2002,204(3),179-184","journal-title":"Dermatology (Basel)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1365-2230.2004.01646.x","volume":"29","author":"Chuh A.A.","year":"2004","unstructured":"Chuh A.A.; Zawar V.; Wong W.C.; Lee A.; Clinical and experimental dermatology. The association of smoking and acne in men in Hong Kong and in India: a retrospective case-control study in primary care settings. Clin Exp Dermatol 2004,29(6),597-599","journal-title":"Clin Exp Dermatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2133.1988.tb02433.x","volume":"118","author":"Walton S.","year":"1988","unstructured":"Walton S.; Wyatt E.H.; Cunliffe W.J.; Genetic control of sebum excretion and acne--a twin study. Br J Dermatol 1988,118(3),393-396","journal-title":"Br J Dermatol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1046\/j.1523-1747.2002.19621.x","volume":"119","author":"Bataille V.","year":"2002","unstructured":"Bataille V.; Snieder H.; MacGregor A.J.; Sasieni P.; Spector T.D.; The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women. J Invest Dermatol 2002,119(6),1317-1322","journal-title":"J Invest Dermatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/jdv.14369","volume":"31","author":"Manfredini M.","year":"2017","unstructured":"Manfredini M.; Greco M.; Farnetani F.; Ciardo S.; De Carvalho N.; Mandel V.D.; Acne: morphologic and vascular study of lesions and surrounding skin by means of optical coherence tomography. J Eur Acad Dermatol Venereol 2017,31(9),1541-1546","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=17","first-page":"43","volume":"52","author":"Liao D.C.","year":"2003","unstructured":"Liao D.C.; Management of acne. J Fam Pract 2003,52(1),43-51","journal-title":"J Fam Pract"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40257-018-0345-x","volume":"19","author":"Trivedi M.K.","year":"2018","unstructured":"Trivedi M.K.; Bosanac S.S.; Sivamani R.K.; Larsen L.N.; Emerging therapies for acne vulgaris. Am J Clin Dermatol 2018,19(4),505-516","journal-title":"Am J Clin Dermatol"},{"key":"ref=19","first-page":"41","volume":"4","author":"Bikowski J.B.","year":"2005","unstructured":"Bikowski J.B.; Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids. J Drugs Dermatol 2005,4(1),41-47","journal-title":"J Drugs Dermatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0190-9622(98)70443-8","volume":"39","author":"Webster G.F.","year":"1998","unstructured":"Webster G.F.; Topical tretinoin in acne therapy. J Am Acad Dermatol 1998,39(2 Pt 3),S38-S44","journal-title":"J Am Acad Dermatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1365-4362.1998.00254.x","volume":"37","author":"Dom\u00ednguez J.","year":"1998","unstructured":"Dom\u00ednguez J.; Hojyo M.T.; Celayo J.L.; Dom\u00ednguez-Soto L.; Teixeira F.; Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris. Int J Dermatol 1998,37(1),54-55","journal-title":"Int J Dermatol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0190-9622(88)70202-9","volume":"19","author":"Elbaum D.J.","year":"1988","unstructured":"Elbaum D.J.; Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne. J Am Acad Dermatol 1988,19(3),486-491","journal-title":"J Am Acad Dermatol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000018255","volume":"199","author":"Glass D.","year":"1999","unstructured":"Glass D.; Boorman G.C.; Stables G.I.; Cunliffe W.J.; Goode K.; A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris. Dermatology (Basel) 1999,199(3),242-247","journal-title":"Dermatology (Basel)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.clindermatol.2016.10.010","volume":"35","author":"Kosmadaki M.","year":"2017","unstructured":"Kosmadaki M.; Katsambas A.; Topical treatments for acne. Clin Dermatol 2017,35(2),173-178","journal-title":"Clin Dermatol"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D33QF1X5T6","volume":"13","author":"Bardazzi F.","year":"2007","unstructured":"Bardazzi F.; Savoia F.; Parente G.; Tabanelli M.; Balestri R.; Spadola G.; Azithromycin: a new therapeutical strategy for acne in adolescents. Dermatol Online J 2007,13(4),4","journal-title":"Dermatol Online J"},{"key":"ref=26","first-page":"391","volume":"14","author":"Dr\u00e9no B.","year":"2004","unstructured":"Dr\u00e9no B.; Bettoli V.; Ochsendorf F.; Layton A.; Mobacken H.; Degreef H.; European Expert Group on Oral Antibiotics in Acne. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 2004,14(6),391-399","journal-title":"Eur J Dermatol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1365-2133.1971.tb14233.x","volume":"84","author":"Cotterill J.A.","year":"1971","unstructured":"Cotterill J.A.; Cunliffe W.J.; Forster R.A.; Williamson D.M.; Bulusu L.; A comparison of trimethoprim-sulphamethoxazole with oxytetracycline in acne vulgaris. Br J Dermatol 1971,84(4),366-369","journal-title":"Br J Dermatol"},{"key":"ref=28","first-page":"40","volume":"4","author":"Leyden J.J.","year":"2011","unstructured":"Leyden J.J.; Del Rosso J.Q.; Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol 2011,4(2),40-47","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=29","first-page":"15","volume":"58","author":"Leydon J.","year":"2008","unstructured":"Leydon J.; Comparing facial tolerability of a 3-step acne system containing a novel solubilized 5% benzoyl peroxide lotion for normal to dry skin with that of a benzoyl peroxide\/clindamycin combination prescription product. J Am Acad Dermatol 2008,58(2)(Suppl. 2),15","journal-title":"J Am Acad Dermatol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/2210681210666200313123550","volume":"10","author":"Nimisha F.Z.","year":"2020","unstructured":"Nimisha F.Z.; Kaur C.D.; Rizvi D.A.; Berberine chloride dihydrate enthused nanovesicles for the management of dermatitis nanovesicles for dermatitis. Nanosci Nanotechnol Asia 2020,10,1","journal-title":"Nanosci Nanotechnol Asia"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaad.2009.03.013","volume":"61","author":"Wang F.","year":"2009","unstructured":"Wang F.; Kwak H.S.; Elbuluk N.; Kaczmarek A.L.; Hamilton T.; Voorhees J.J.; Retinoic acid 4-hydroxylase inducibility and clinical response to isotretinoin in patients with acne. J Am Acad Dermatol 2009,61(2),252-258","journal-title":"J Am Acad Dermatol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0939-6411(99)00021-1","volume":"48","author":"Gabri\u00ebls M.","year":"1999","unstructured":"Gabri\u00ebls M.; Brisaert M.; Plaizier-Vercammen J.; Densitometric thin layer chromatographic analysis of tretinoin and erythromycin in lotions for topical use in acne treatment. Eur J Pharm Biopharm 1999,48(1),53-58","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0149-2918(98)80134-3","volume":"20","author":"Spellman M.C.","year":"1998","unstructured":"Spellman M.C.; Pincus S.H.; Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne. Clin Ther 1998,20(4),711-721","journal-title":"Clin Ther"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/S0190-9622(97)70051-3","volume":"36","author":"Verschoore M.","year":"1997","unstructured":"Verschoore M.; Poncet M.; Czernielewski J.; Sorba V.; Clucas A.; Adapalene 0.1% gel has low skin-irritation potential. J Am Acad Dermatol 1997,36(6 Pt 2),S104-S109","journal-title":"J Am Acad Dermatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.clinthera.2004.11.012","volume":"26","author":"Shalita A.R.","year":"2004","unstructured":"Shalita A.R.; Berson D.S.; Thiboutot D.M.; Leyden J.J.; Parizadeh D.; Sefton J.; Tazarotene cream in acne clinical study investigator group. effects of tazarotene 0.1% cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials. Clin Ther 2004,26(11),1865-1873","journal-title":"Clin Ther"},{"key":"ref=36","first-page":"139","volume":"21","author":"Xu Y.L.","year":"2006","unstructured":"Xu Y.L.; Yang X.X.; Xu S.; Preparation and evaluation of tea tree oil liposome. Huaxi Yaoxue Zazhi 2006,21(2),139","journal-title":"Huaxi Yaoxue Zazhi"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaad.2003.10.078","volume":"50","author":"Rougier A.M.","year":"2004","unstructured":"Rougier A.M.; Richard A.; Efficacy and safety of a new salicylic acid derivative as a complement of vitamin A acid in acne treatment. J Am Acad Dermatol 2004,50(3),19","journal-title":"J Am Acad Dermatol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jaad.2003.10.094","volume":"50","author":"Yaroshinsky A.","year":"2004","unstructured":"Yaroshinsky A.; Leyden J.; The safety and efficacy of clindamycin (1% as clindamycin phosphate and tretinoin (0.025%)] for the treatment of acne vulgaris: a combined analysis of results from six controlled safety and efficacy trials conducted in Europe 1. J Am Acad Dermatol 2004,50(3),23","journal-title":"J Am Acad Dermatol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0378-5173(98)00366-4","volume":"178","author":"Vermeulen B.","year":"1999","unstructured":"Vermeulen B.; Remon J.P.; Nelis H.; The formulation and stability of erythromycin-benzoyl peroxide in a topical gel. Int J Pharm 1999,178(1),137-141","journal-title":"Int J Pharm"},{"key":"ref=40","first-page":"981","volume":"6","author":"Lucky A.W.","year":"2007","unstructured":"Lucky A.W.; Maloney J.M.; Roberts J.; Taylor S.; Jones T.; Ling M.; Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment. J Drugs Dermatol Dapsone Gel Long-Term Safety Study Group2007,6(10),981-987","journal-title":"J Drugs Dermatol"},{"key":"ref=41","first-page":"26","volume":"2","author":"Del Rosso J.Q.","year":"2009","unstructured":"Del Rosso J.Q.; The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. J Clin Aesthet Dermatol 2009,2(8),26-29","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1159\/000089138","volume":"19","author":"Date A.A.","year":"2006","unstructured":"Date A.A.; Naik B.; Nagarsenker M.S.; Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol 2006,19(1),2-16","journal-title":"Skin Pharmacol Physiol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0378-5173(98)00006-4","volume":"165","author":"Gulati M.","year":"1998","unstructured":"Gulati M.; Grover M.; Singh S.; Singh M.; Lipophilic drug derivatives in liposomes. Int J Pharm 1998,165(2),129-168","journal-title":"Int J Pharm"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/S1359-6446(03)02903-9","volume":"8","author":"Sahoo S.K.","year":"2003","unstructured":"Sahoo S.K.; Labhasetwar V.; Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003,8(24),1112-1120","journal-title":"Drug Discov Today"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0168-3659(97)00261-7","volume":"53","author":"Gabizon A.","year":"1998","unstructured":"Gabizon A.; Goren D.; Cohen R.; Barenholz Y.; Development of liposomal anthracyclines: from basics to clinical applications. J Control Release 1998,53(1-3),275-279","journal-title":"J Control Release"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2165\/00003495-199700544-00004","volume":"54","author":"Allen T.M.","year":"1997","unstructured":"Allen T.M.; Liposomes. Opportunities in drug delivery. Drugs 1997,54(4)(Suppl. 4),8-14","journal-title":"Drugs"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.bbamem.2007.01.019","volume":"1768","author":"Johnston M.J.","year":"2007","unstructured":"Johnston M.J.; Semple S.C.; Klimuk S.K.; Ansell S.; Maurer N.; Cullis P.R.; Characterization of the drug retention and pharmacokinetic properties of liposomal nanoparticles containing dihydrosphingomyelin. Biochim Biophys Acta 2007,1768(5),1121-1127","journal-title":"Biochim Biophys Acta"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1556-276X-8-102","volume":"8","author":"Akbarzadeh A.","year":"2013","unstructured":"Akbarzadeh A.; Rezaei-Sadabady R.; Davaran S.; Joo S.W.; Zarghami N.; Hanifehpour Y.; Liposome: classification, preparation, and applications. Nanoscale Res Lett 2013,8(1),102","journal-title":"Nanoscale Res Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/01.cad.0000167902.53039.5a","volume":"16","author":"Hofheinz R.D.","year":"2005","unstructured":"Hofheinz R.D.; Gnad-Vogt S.U.; Beyer U.; Hochhaus A.; Liposomal encapsulated anti-cancer drugs. Anticancer Drugs 2005,16(7),691-707","journal-title":"Anticancer Drugs"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/0024-3205(80)90268-4","volume":"26","author":"Mezei M.","year":"1980","unstructured":"Mezei M.; Gulasekharam V.; Liposomes--a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980,26(18),1473-1477","journal-title":"Life Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/1523-1747.ep12611886","volume":"99","author":"Lieb L.M.","year":"1992","unstructured":"Lieb L.M.; Ramachandran C.; Egbaria K.; Weiner N.; Topical delivery enhancement with multilamellar liposomes into pilosebaceous units: I. In vitro evaluation using fluorescent techniques with the hamster ear model. J Invest Dermatol 1992,99(1),108-113","journal-title":"J Invest Dermatol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3851\/IMP1684","volume":"21","author":"Lembo D.","year":"2010","unstructured":"Lembo D.; Cavalli R.; Nanoparticulate delivery systems for antiviral drugs. Antivir Chem Chemother 2010,21(2),53-70","journal-title":"Antivir Chem Chemother"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0378-5173(92)90138-R","volume":"85","author":"\u0160kalko N.","year":"1992","unstructured":"\u0160kalko N.; \u010cajkovac M.; Jal\u0161enjak I.; Liposomes with clindamycin hydrochloride in the therapy of acne vulgaris. Int J Pharm 1992,85(1-3),97-101","journal-title":"Int J Pharm"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"R044","DOI":"10.1007\/s004240000000","volume":"440","author":"Honzak L.","year":"2000","unstructured":"Honzak L.; \u0160entjurc M.; Development of liposome encapsulated clindamycin for treatment of acne vulgaris. Pflugers Arch 2000,440(1)(Suppl. 1),R044-R045","journal-title":"Pflugers Arch"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.5958\/0974-360X.2019.01038.2","volume":"12","author":"Sankar C.","year":"2019","unstructured":"Sankar C.; Muthukumar S.; Arulkumaran G.; Shalini S.; Sundaraganapathy R.; Formulation and Characterization of Liposomes containing Clindamycin and Green tea for Anti Acne. Research Journal of Pharmacy and Technology 2019,12(12),5977-5984","journal-title":"Research Journal of Pharmacy and Technology"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/03639045.2018.1546310","volume":"45","author":"Madan S.","year":"2019","unstructured":"Madan S.; Nehate C.; Barman T.K.; Rathore A.S.; Koul V.; Design, preparation, and evaluation of liposomal gel formulations for treatment of acne: in vitro and in vivo studies. Drug Dev Ind Pharm 2019,45(3),395-404","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=57","first-page":"1","volume":"30","author":"Aytekin A.A.","year":"2019","unstructured":"Aytekin A.A.; Tuncay Tanr\u0131verdi S.; Ayd\u0131n K\u00f6se F.; Kart D.; Ero\u011flu \u0130.; \u00d6zer \u00d6.; Propolis loaded liposomes: evaluation of antimicrobial and antioxidant activities. J Liposome Res 2019,30(2),1-0","journal-title":"J Liposome Res"},{"key":"ref=58","first-page":"81","volume":"31","author":"Malhotra M.","year":"1994","unstructured":"Malhotra M.; Jain N.K.; Niosomes as drug carriers. Indian Drugs-Bombay 1994,31,81","journal-title":"Indian Drugs-Bombay"},{"key":"ref=59","author":"Udupa N.","year":"2002","unstructured":"Udupa N.; Niosomes as drug carriers Controlled and novel drug delivery 2002","journal-title":"Niosomes as drug carriers Controlled and novel drug delivery"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.2042-7158.1985.tb04990.x","volume":"37","author":"Baillie A.J.","year":"1985","unstructured":"Baillie A.J.; Florence A.T.; Hume L.R.; Muirhead G.T.; Rogerson A.; The preparation and properties of niosomes--non-ionic surfactant vesicles. J Pharm Pharmacol 1985,37(12),863-868","journal-title":"J Pharm Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0378-5173(99)00122-2","volume":"185","author":"Hu C.","year":"1999","unstructured":"Hu C.; Rhodes D.G.; Proniosomes: a novel drug carrier preparation. Int J Pharm 1999,185(1),23-35","journal-title":"Int J Pharm"},{"key":"ref=62","first-page":"570","volume":"75","author":"Brewer J.M.","year":"1992","unstructured":"Brewer J.M.; Alexander J.; The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB\/c humoral response to bovine serum albumin. Immunology 1992,75(4),570-575","journal-title":"Immunology"},{"key":"ref=63","first-page":"192","volume":"64","author":"Moser P.","year":"1989","unstructured":"Moser P.; Marchand-Arvier M.; Labrude P.; Handjani-Vila R.M.; Vigneron C.; Hemoglobin niosomes. I. Preparation, functional and physico-chemical properties, and stability Pharm Acta Helv 1989,64(7),192-202","journal-title":"Pharm Acta Helv"},{"key":"ref=64","first-page":"82","volume":"65","author":"Moser P.","year":"1990","unstructured":"Moser P.; Marchand-Arvier M.; Labrude P.; Vigneron C.; Hemoglobin niosomes. II. In vitro interactions of plasma proteins and phagocytes Pharm Acta Helv 1990,65(3),82-92","journal-title":"Pharm Acta Helv"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.2042-7158.1988.tb05210.x","volume":"40","author":"Hunter C.A.","year":"1988","unstructured":"Hunter C.A.; Dolan T.F.; Coombs G.H.; Baillie A.J.; Vesicular systems (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J Pharm Pharmacol 1988,40(3),161-165","journal-title":"J Pharm Pharmacol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/0110-5558.76435","volume":"1","author":"Kazi K.M.","year":"2010","unstructured":"Kazi K.M.; Mandal A.S.; Biswas N.; Guha A.; Chatterjee S.; Behera M.; Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 2010,1(4),374-380","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1023\/A:1018963910260","volume":"11","author":"Hofland H.E.","year":"1994","unstructured":"Hofland H.E.; van der Geest R.; Bodde H.E.; Junginger H.E.; Bouwstra J.A.; Estradiol permeation from nonionic surfactant vesicles through human stratum corneum in vitro. Pharm Res 1994,11(5),659-664","journal-title":"Pharm Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0378-5173(01)00971-1","volume":"234","author":"Manconi M.","year":"2002","unstructured":"Manconi M.; Sinico C.; Valenti D.; Loy G.; Fadda A.M.; Niosomes as carriers for tretinoin. I. Preparation and properties. Int J Pharm 2002,234(1-2),237-248","journal-title":"Int J Pharm"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","volume":"1","author":"Kumar G.P.","year":"2011","unstructured":"Kumar G.P.; Rajeshwarrao P.; Nonionic surfactant vesicular systems for effective drug delivery\u2014an overview. Acta Pharm Sin B 2011,1(4),208-219","journal-title":"Acta Pharm Sin B"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3109\/10717544.2014.896428","volume":"22","author":"Rahman S.A.","year":"2015","unstructured":"Rahman S.A.; Abdelmalak N.S.; Badawi A.; Elbayoumy T.; Sabry N.; El Ramly A.; Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study. Drug Deliv 2015,22(6),731-739","journal-title":"Drug Deliv"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3109\/10717544.2014.903010","volume":"22","author":"Budhiraja A.","year":"2015","unstructured":"Budhiraja A.; Dhingra G.; Development and characterization of a novel antiacne niosomal gel of rosmarinic acid. Drug Deliv 2015,22(6),723-730","journal-title":"Drug Deliv"},{"key":"ref=72","first-page":"171","volume":"10","author":"Gupta A.","year":"2014","unstructured":"Gupta A.; Singh S.; Kotla N.G.; Webster T.J.; Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int J Nanomedicine 2014,10,171-182","journal-title":"Int J Nanomedicine"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3109\/10717544.2013.855277","volume":"22","author":"Goyal G.","year":"2015","unstructured":"Goyal G.; Garg T.; Malik B.; Chauhan G.; Rath G.; Goyal A.K.; Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv 2015,22(8),1027-1042","journal-title":"Drug Deliv"},{"key":"ref=74","first-page":"123","volume":"3","author":"Jigar V.","year":"2011","unstructured":"Jigar V.; Puja V.; Krutika S.; Formulation and evaluation of topical niosomal gel of erythromycin. Int J Pharm Pharm Sci 2011,3(1),123-126","journal-title":"Int J Pharm Pharm Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","volume":"65","author":"Touitou E.","year":"2000","unstructured":"Touitou E.; Dayan N.; Bergelson L.; Godin B.; Eliaz M.; Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000,65(3),403-418","journal-title":"J Control Release"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1872210514666200204124130","volume":"14","author":"Pandey K.","year":"2020","unstructured":"Pandey K.; Nimisha. An overview on promising nanotechnological approaches for the treatment of psoriasis. Recent Pat Nanotechnol 2020,14,1","journal-title":"Recent Pat Nanotechnol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"S587","DOI":"10.4103\/pm.pm_210_17","volume":"13","year":"2017","unstructured":"Nimisha, Rizvi DA, Fatima Z, Neema, Kaur CD. Antipsoriatic and anti-inflammatory studies of Berberis aristata extract loaded nanovesicular gels. Pharmacogn Mag 2017,13(Suppl. 3),S587-S594","journal-title":"Pharmacogn Mag"},{"key":"ref=78","first-page":"17","volume":"1","author":"Anitha P.","year":"2011","unstructured":"Anitha P.; Ramkanth S.; Sankari K.U.; Alagusundaram M.; Gnanapraksah K.; Devi D.P.; Ethosomes-A noninvasive vesicular carrier for transdermal drug delivery. Int J Rev Life Sci 2011,1(1),17-24","journal-title":"Int J Rev Life Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/0110-5558.72415","volume":"1","author":"Verma P.","year":"2010","unstructured":"Verma P.; Pathak K.; Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res 2010,1(3),274-282","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=80","first-page":"2008","volume":"6","author":"Razavi H.","year":"2015","unstructured":"Razavi H.; Janfaza S.; Ethosomes: a nanocarrier for transdermal drug delivery. J Paramed Sci Spring 2015,6(2),2008-4987","journal-title":"J Paramed Sci Spring"},{"key":"ref=81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159967","volume":"11","author":"Yu Z.","year":"2016","unstructured":"Yu Z.; Lv H.; Han G.; Ma K.; Ethosomes loaded with cryptotanshinone for acne treatment through topical gel formulation. PLoS One 2016,11(7)","journal-title":"PLoS One"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.5530\/ijper.50.3.34","volume":"50","author":"Mistry A.","year":"2016","unstructured":"Mistry A.; Ravikumar P.; Development and evaluation of azelaic acid based ethosomes for topical delivery for the treatment of acne. Ind J Pharm Educ Res 2016,50(3),S232-S243","journal-title":"Ind J Pharm Educ Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jddst.2018.11.016","volume":"49","author":"Kausar H","year":"2019","unstructured":"Kausar H; Muj eb M; Ahad A; Moolakkadath T; Aqil M; Ahmad A; Optimization of ethosomes for topical thymoquinone delivery for the treatment of skin acne. J Drug Deliv Sci Technol 2019,49,177-187","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=84","first-page":"28","volume":"5","author":"David S.R.","year":"2013","unstructured":"David S.R.; Hui M.S.; Pin C.F.; Ci F.Y.; Rajabalaya R.; Formulation and in vitro evaluation of ethosomes as vesicular carrier for enhanced topical delivery of isotretinoin. Int J Drug Deliv 2013,5(1),28","journal-title":"Int J Drug Deliv"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v13.i3-4.30","volume":"13","author":"Cevc G.","year":"1996","unstructured":"Cevc G.; Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Critical reviews\u2122 in therapeutic drug carrier systems 1996,13,3-4","journal-title":"Critical reviews\u2122 in therapeutic drug carrier systems"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/2210681209666190919095128","volume":"9","author":"Nimisha S.A.","year":"2019","unstructured":"Nimisha S.A.; Chaubey R.; enhancement of dissolution rate of quercetin using solid dispersion approach: in vitro","journal-title":"Nanosci Nanotechnol Asia"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1080\/20022727.2017.1325708","volume":"18","author":"Rai S.","year":"2017","unstructured":"Rai S.; Pandey V.; Rai G.; Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art. Nano Rev Exp 2017,18(1)","journal-title":"Nano Rev Exp"},{"key":"ref=88","first-page":"71","volume":"2","author":"Modi C.D.","year":"2012","unstructured":"Modi C.D.; Bharadia P.D.; Transfersomes: new dominants for transdermal drug delivery. Am J Pharm Tech Res 2012,2(3),71-91","journal-title":"Am J Pharm Tech Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4103\/1735-5362.236831","volume":"13","author":"Hasanpouri A.","year":"2018","unstructured":"Hasanpouri A.; Lotfipour F.; Ghanbarzadeh S.; Hamishehkar H.; Improvement of dermal delivery of tetracycline using vesicular nanostructures. Res Pharm Sci 2018,13(5),385-393","journal-title":"Res Pharm Sci"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.5530\/jyp.2018.2s.3","volume":"10","author":"Rahmi A.D.","year":"2018","unstructured":"Rahmi A.D.; Pangesti D.M.; Comparison of the characteristics of transfersomes and protransfersomes containing azelaic acid. J Young Pharm 2018,10(2s),S11-S15","journal-title":"J Young Pharm"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/pharmaceutics10010026","volume":"10","author":"Qushawy M.","year":"2018","unstructured":"Qushawy M.; Nasr A.; Abd-Alhaseeb M.; Swidan S.; Design, optimization and characterization of a transfersomal gel using miconazole nitrate for the treatment of candida skin infections. Pharmaceutics 2018,10(1),26","journal-title":"Pharmaceutics"},{"key":"ref=92","first-page":"765","volume":"6","author":"Gupta M.","year":"2017","unstructured":"Gupta M.; Prajapati R.N.; Irchhaiya R.; Singh N.; Prajapati S.K.; Novel clindamycin loaded transfersomes formulation for effective management of acne. World. Res J Pharm Res 2017,6(6),765-773","journal-title":"Res J Pharm Res"},{"key":"ref=93","first-page":"20","volume":"2","author":"Fadel M.","year":"2015","unstructured":"Fadel M.; Kassab K.; Samy N.; Thabet S.; Indocyanine green transferosomal hydrogel with enhanced stability and skin permeation for treatment of acne vulgaris: (in-vitro and clinical study). EJPBS 2015,2,20-36","journal-title":"EJPBS"},{"key":"ref=94","first-page":"1","volume":"1","author":"Rafieian-Kopaei M.","year":"2012","unstructured":"Rafieian-Kopaei M.; Medicinal plants and the human needs. J HerbMed Pharm 2012,1,1","journal-title":"J HerbMed Pharm"},{"key":"ref=95","first-page":"35","volume":"3","author":"Mardani S.","year":"2014","unstructured":"Mardani S.; Nasri H.; Hajian S.; Ahmadi A.; Kazemi R.; Rafieian-Kopaei M.; Impact of Momordica charantia extract on kidney function and structure in mice. J Nephropathol 2014,3(1),35-40","journal-title":"J Nephropathol"},{"key":"ref=96","first-page":"3","volume":"2","author":"Rafieian-Kopaei M.","year":"2013","unstructured":"Rafieian-Kopaei M.; Baradaran A.; Teucrium polium and kidney. J Renal Inj Prev 2013,2(1),3-4","journal-title":"J Renal Inj Prev"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4103\/0110-5558.72416","volume":"1","author":"Kaity S.","year":"2010","unstructured":"Kaity S.; Maiti S.; Ghosh A.K.; Pal D.; Ghosh A.; Banerjee S.; Microsponges: A novel strategy for drug delivery system. J Adv Pharm Technol Res 2010,1(3),283-290","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=98","first-page":"529","volume":"42","author":"Rafieian-Kopaei M.","year":"2013","unstructured":"Rafieian-Kopaei M.; Nasri H.; Alizadeh F.; Ataei B.; Baradaran A.; Immunoglobulin A nephropathy and malaria falciparum infection; a rare association. Iran J Public Health 2013,42(5),529-533","journal-title":"Iran J Public Health"},{"key":"ref=99","first-page":"5444","volume":"Vol 26","author":"Collier K.","year":"1999","unstructured":"Collier K.; Matalonis S.; Owen A.J.; Evaluation of permeability enhancement by microemulsion in a Caco-2 cell system. InProc Int Symp Control Release Bioact Mater 1999,Vol 26,5444","journal-title":"InProc Int Symp Control Release Bioact Mater"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/01932690208984214","volume":"23","author":"Marti-Mestres G.","year":"2002","unstructured":"Marti-Mestres G.; Nielloud F.; Emulsions in health care applications\u2014an overview. J Dispers Sci Technol 2002,23(1-3),419-439","journal-title":"J Dispers Sci Technol"},{"key":"ref=101","first-page":"176","volume":"11","author":"Nimisha F.Z.","year":"2017","unstructured":"Nimisha F.Z.; Kaur C.D.; formulation and performance evaluation of berberis aristata extract loaded ethosomal gel. Asian. J Pharm 2017,11(3),176-183","journal-title":"J Pharm"},{"key":"ref=102","first-page":"299","volume":"42","author":"Nacht S.","year":"1990","unstructured":"Nacht S.; Katz M.; The microsponge: a novel topical programmable delivery system. Drugs Pharm Sci 1990,42,299-325","journal-title":"Drugs Pharm Sci"},{"key":"ref=103","first-page":"95","volume":"95","author":"Alebiosu C.O.","year":"2003","unstructured":"Alebiosu C.O.; Ogunledun A.; Ogunleye D.S.; A report of clinical trial conducted on Toto ointment and soap products. J Natl Med Assoc 2003,95(1),95-105","journal-title":"J Natl Med Assoc"},{"key":"ref=104","first-page":"987","volume":"6","author":"Nimisha F.Z.","year":"2016","unstructured":"Nimisha F.Z.; Kaur CD. A review on potential of novel vesicular carriers for carrying herbal drugs in the treatment of dermatological disorders. J Atoms Mol 2016,6(3),987","journal-title":"J Atoms Mol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0378-8741(01)00323-3","volume":"78","author":"Lalla J.K.","year":"2001","unstructured":"Lalla J.K.; Nandedkar S.Y.; Paranjape M.H.; Talreja N.B.; Clinical trials of ayurvedic formulations in the treatment of acne vulgaris. J Ethnopharmacol 2001,78(1),99-102","journal-title":"J Ethnopharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"260","DOI":"10.17305\/bjbms.2010.2697","volume":"10","author":"Mahmood T.","year":"2010","unstructured":"Mahmood T.; Akhtar N.; Khan B.A.; Khan H.M.; Saeed T.; Outcomes of 3% green tea emulsion on skin sebum production in male volunteers. Bosn J Basic Med Sci 2010,10(3),260-264","journal-title":"Bosn J Basic Med Sci"},{"key":"ref=107","first-page":"249","volume":"101","author":"Ravichandran G.","year":"2004","unstructured":"Ravichandran G.; Bharadwaj V.S.; Kolhapure S.A.; Evaluation of efficacy and safety of Acne-N-Pimple cream in acne vulgaris. Antiseptic 2004,101(12),249","journal-title":"Antiseptic"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"455","DOI":"10.5694\/j.1326-5377.1990.tb126150.x","volume":"153","author":"Bassett I.B.","year":"1990","unstructured":"Bassett I.B.; Pannowitz D.L.; Barnetson R.S.; A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990,153(8),455-458","journal-title":"Med J Aust"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.33320\/maced.pharm.bull.2016.62.02.001","volume":"62","author":"Sibinovska N.","year":"2016","unstructured":"Sibinovska N.; Komoni V.; Netkovska K.A.; Vranic E.; Crcarevska M.S.; Dodov M.G.; Novel approaches in treatment of acne vulgaris: patents related to micro\/nanoparticulated carrier systems. Macedonian Pharm Bull 2016,62(2),3-16","journal-title":"Macedonian Pharm Bull"},{"key":"ref=110","author":"Handjani RM","year":"1989","unstructured":"Handjani RM; Ribier A; Vanlerberghe G; Zabotto A; Griat J; Cosmetic and pharmaceutical compositions containing niosomes and a water-soluble polyamide, and a process for preparing these compositions US4830857 1989","journal-title":"US4830857"},{"key":"ref=111","author":"Rasochova L","year":"2019","unstructured":"Rasochova L; Michelle KE; Compositions and methods for treating acne vulgaris US16302637 2019","journal-title":"US16302637"},{"key":"ref=112","author":"Perricone NV","year":"2014","unstructured":"Perricone NV; Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system US8871254 2014","journal-title":"US8871254"},{"key":"ref=113","author":"Vivanco RC","year":"2012","unstructured":"Vivanco RC; Bejarano RA; Torres DP; Inventors; Pharmabrand SA. Composition comprising mucilaginous polysaccharides derived from aloe barbadensis and method for obtaining same and use thereof US8334001 2012","journal-title":"US8334001"},{"key":"ref=114","author":"Wei X","year":"2017","unstructured":"Wei X; Dong M; Yujie J.; A kind of transdermal drug delivery system of alcohol liposome containing hyaluronic acid and preparation method and application. CN106955277(A) 2017","journal-title":"CN106955277(A)"},{"key":"ref=115","author":"Edelson J","year":"2015","unstructured":"Edelson J; Cotilla T; Zhang B.; Dermal delivery CN105147608(B) 2015","journal-title":"CN105147608(B)"},{"key":"ref=116","author":"Perricone NV","year":"2014","unstructured":"Perricone NV; Treatment of skin and soft tissue infection with nitric oxide US8871255 2014","journal-title":"US8871255"},{"key":"ref=117","author":"Tan J","year":"2012","unstructured":"Tan J; Jiang L; Chang T; Zhou Z; Bullatacin ethosome gel and preparation method thereof CN102552147(A) 2012","journal-title":"CN102552147(A)"},{"key":"ref=118","author":"Tan J","year":"2012","unstructured":"Tan J; Jiang L; Chang T; Zhou Z; Paclitaxel ethosome gel and preparation method thereof CN102552147A 2012","journal-title":"CN102552147A"},{"key":"ref=119","author":"Pisano C","year":"2009","unstructured":"Pisano C; Vesci L; Use of adamatyl methoxydiphenyl propenoic acid for the treatment of acne. US7635719 2009","journal-title":"US7635719"},{"key":"ref=120","author":"Ayala FA","year":"2009","unstructured":"Ayala FA; Topical antiacne preparations containing retinoid (tazarotene or adapalene), antibiotic (clindamycin phosphate) and\/or keratolytic (microsponged benzoyl peroxide) US12\/375592 2009","journal-title":"US12\/375592"},{"key":"ref=121","author":"Susan M","year":"2008","unstructured":"Susan M; Glen A; Nassiti D.; Novel topical formulations KR 20010049428(A) 2008","journal-title":"KR 20010049428(A)"},{"key":"ref=122","author":"Dorogi P","year":"2007","unstructured":"Dorogi P; Vasily D; McCook J; Skin treatment compositions containing copper-pigment complexes. US11\/320280 2007","journal-title":"US11\/320280"},{"key":"ref=123","author":"Bouwstra JA","year":"1998","unstructured":"Bouwstra JA; Phospholipid-and cholestrol-free aqueous composition for topical application to the skin US5830499 1998","journal-title":"US5830499"},{"key":"ref=124","author":"Wolf BA","year":"1995","unstructured":"Wolf BA; Snyder F; Cosmetic compositions having keratolytic and anti-acne activity US5449519 1995","journal-title":"US5449519"},{"key":"ref=125","author":"Meybeck A.","year":"1991","unstructured":"Meybeck A.; Michelon P.; Montastier C.; Redziniak G.G.; Pharmaceutical composition, in particular dermatological or cosmetic, comprising hydrous lipidic lamellar phases or liposomes containing a retinoid or a structural analogue thereof such as a carotenoid 1991","journal-title":"Pharmaceutical composition, in particular dermatological or cosmetic, comprising hydrous lipidic lamellar phases or liposomes containing a retinoid or a structural analogue thereof such as a carotenoid"}],"container-title":["Recent Patents on Anti-Infective Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184345","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184345\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T02:11:57Z","timestamp":1696471917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184345\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,11,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574891x15999200729192138","relation":{},"ISSN":["1574-891X"],"issn-type":[{"value":"1574-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}